300937.SZ
药易购
SZSE · F 批发零售 · CN
CNY 25.16
−3.68%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 4.4B | 4.5B | 4.4B | 4.4B | 4.0B |
| Cost of Revenue | 4.0B | 4.0B | 4.0B | 4.1B | 3.7B |
| Gross Profit | 451.3M | 463.9M | 392.7M | 367.6M | 315.4M |
| Operating Expenses | |||||
| R&D Expense | 10.5M | 10.7M | 15.5M | 19.3M | 17.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 79.5M | 77.7M | 74.0M | 57.5M | 59.6M |
| Selling & Marketing Expense | 313.8M | 324.1M | 254.3M | 190.6M | 161.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 421.3M | 431.0M | 361.7M | 281.9M | 253.2M |
| Cost and Expenses | 4.4B | 4.4B | 4.4B | 4.3B | 3.9B |
| Operating Income (EBIT) | 5.8M | 8.9M | 10.0M | 68.6M | 47.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 4.1M | 7.2M | 12.0M | 69.9M | 44.9M |
| Income Tax Expense | 23.6M | 23.6M | 963.6K | 13.1M | 8.8M |
| Bottom Line | |||||
| Net Income | (19.8M) | (12.9M) | 13.2M | 59.5M | 42.0M |
| Earnings from Cont. Ops | (19.5M) | (16.5M) | 11.0M | 56.8M | 36.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (19.8M) | (12.9M) | 13.2M | 59.5M | 42.0M |
| Per Share | |||||
| Basic EPS | (CN¥0.21) | (CN¥0.13) | CN¥0.14 | CN¥0.62 | CN¥0.44 |
| Diluted EPS | (CN¥0.21) | (CN¥0.13) | CN¥0.14 | CN¥0.62 | CN¥0.44 |
| Revenue Per Share | CN¥52.61 | CN¥46.54 | CN¥45.94 | CN¥46.14 | CN¥41.57 |
| Shares | |||||
| Basic Shares Outstanding | 84.2M | 95.7M | 95.7M | 96.0M | 95.5M |
| Diluted Shares Outstanding | 84.2M | 95.7M | 95.7M | 96.0M | 95.5M |
| Profitability Metrics | |||||
| EBITDA | — | 39.3M | 39.5M | 93.8M | 69.5M |
| D&A | — | 30.4M | 29.6M | 25.2M | 22.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026